Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT01568970
Other study ID # 2010/2404
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date January 2012
Est. completion date September 2018

Study information

Verified date December 2018
Source Norwegian University of Science and Technology
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The large number of people on long-term sick leave is a major public health concern in Norway. The main causes of disability are musculoskeletal and mental disorders. Long-term sick leave causes a decline in individual life-quality, is associated with increased risk for mental disorders and represents a very large cost for the Norwegian society.

The purpose of this study is to determine whether the patients included return to work after rehabilitation at Hysnes Rehabilitation Centre. This includes an investigation of what is considered to be the effect of Return-to-work rehabilitation measured before, during and after the stay at the rehabilitation centre:

The study specifically looks at the effect of structured and standardized return-to-work follow up of the patient, including contact with stakeholders (general practitioner, social security office and workplace).

In addition there is a need to describe the patients participating in the program. The aetiology of complex symptom disorders is poorly understood and the role of genetics and stress is not translatable to a complex symptom population. This complicates the transition from current biological research to a clinical use regarding these patients. If the investigators can assist in understanding how these patients, who are multiusers of health care and have received sickness benefit for a long time, develop their disorders and symptoms, it will be of great importance to the Norwegian community. Therefore the study consists of multimodal measurements of the patients before, during and after a rehabilitation programme at Hysnes Rehabilitation Centre. These measures include genotype, saliva cortisol, medical-, psychological-, physiological diagnostics and work related factors.

Related aims:

Investigate if multidisciplinary treatment based on acceptance and commitment therapy, contributes to normalisation of cortisol release with regards to a standardized stress test.

See wether individual differences regarding the stress profile can predict return to work in patients with complex symptom disorders.

Investigate genetic risk factors in relation to Return to Work rehabilitation and identify treatment moderators in a multidisciplinary rehabilitation program.


Recruitment information / eligibility

Status Completed
Enrollment 214
Est. completion date September 2018
Est. primary completion date June 2014
Accepts healthy volunteers No
Gender All
Age group 18 Years to 59 Years
Eligibility Inclusion criteria:

- Age between 18-59 years

- A self defined goal of increasing their work ability and work participation within a period of no more than six months

- They fill the criteria of a complex symptom disorder, or they are diagnosed with a common mental disorder

- A satisfactory level of examination and treatment to participate at Hysnes Rehabilitation Centre

- Sick leave > 8weeks or receiving work ability assessment benefit for any diagnosis, except as stated below.

- On a level of linguistic, physical and mental function required to participate in the rehabilitation

Exclusion criteria:

- Ongoing alcohol/drug abuse

- Ongoing psychosis, ongoing manic episode or suicide risk

- Pregnancy

Study Design


Related Conditions & MeSH terms


Intervention

Behavioral:
Return-to-work Rehabilitation + Follow up
3 1/2 weeks of Return-to-work rehabilitation followed by 6 months of Return-to-work follow-up
Return-to-work rehabilitation
3 1/2 weeks of Return-to-work rehabilitation followed by standard follow-up

Locations

Country Name City State
Norway Hysnes Helsefort, St Olavs Hospital Trondheim

Sponsors (1)

Lead Sponsor Collaborator
Norwegian University of Science and Technology

Country where clinical trial is conducted

Norway, 

References & Publications (1)

Hara KW, Bjørngaard JH, Brage S, Borchgrevink PC, Halsteinli V, Stiles TC, Johnsen R, Woodhouse A. Randomized Controlled Trial of Adding Telephone Follow-Up to an Occupational Rehabilitation Program to Increase Work Participation. J Occup Rehabil. 2018 Ju — View Citation

Outcome

Type Measure Description Time frame Safety issue
Primary Return to work Differences in cumulative days of sick leave, as reported by the government database "FD-Trygd". 1 year after the end of the stay at the rehabilitation center.
Secondary quality of life Quality of life is assessed by 15D, SF8 and function subscale in SF-36 5 years after the end of the rehabilitation stay
Secondary Functional status Functional status will be measured with elements from the Norwegian Function Assessment Scale (Osteras et al., 2007) and the function subscale of SF-36 (Ware Jr & Sherbourne, 1992) 5 year after the end of the rehabilitation stay
Secondary level of symptoms (somatic and psychological) The Hospital Anxiety and Depression Scale (HADS) measure changes in anxiety and depression.
Changes regarding physical and mental fatigue are registered through the Chalder Fatigue Questionnaire.
Changes in participants subjective experience of pain measured by numerical rating scale (NRS)
5 year after the end of the rehabilitation stay,